Skip Nav Destination
Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte–derived macrophages
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in patients with high disability scores
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials
Issue Archive
October 1 2003
Table of Contents
INSIDE BLOOD
BLOOD WORK
REVIEW ARTICLES
CHEMOKINES
Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte–derived macrophages
Brief Report
Laura Fantuzzi,Francesca Spadaro,Giuliana Vallanti,Irene Canini,Carlo Ramoni,Elisa Vicenzi,Filippo Belardelli,Guido Poli,Sandra Gessani
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma
Clinical Trials & Observations
Ranjit K. Dasgupta,Peter J. Adamson,Faith E. Davies,Sara Rollinson,Philippa L. Roddam,A. John Ashcroft,Ann M. Dring,James A. L. Fenton,J. Anthony Child,James M. Allan,Gareth J. Morgan
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis
Clinical Trials & Observations
Ajay K. Gopal,Theodore A. Gooley,David G. Maloney,Stephen H. Petersdorf,Janet F. Eary,Joseph G. Rajendran,Sharon A. Bush,Lawrence D. Durack,Jane Golden,Paul J. Martin,Dana C. Matthews,Frederick R. Appelbaum,Irwin D. Bernstein,Oliver W. Press
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
Clinical Trials & Observations
Richard A. Nash,James D. Bowen,Peter A. McSweeney,Steven Z. Pavletic,Kenneth R. Maravilla,Man-soo Park,Jan Storek,Keith M. Sullivan,Jinan Al-Omaishi,John R. Corboy,John DiPersio,George E. Georges,Theodore A. Gooley,Leona A. Holmberg,C. Fred LeMaistre,Kate Ryan,Harry Openshaw,Julie Sunderhaus,Rainer Storb,Joseph Zunt,George H. Kraft
Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in patients with high disability scores
Clinical Trials & Observations
Richard K. Burt,Bruce A. Cohen,Eric Russell,Kenneth Spero,Akash Joshi,Yu Oyama,William J. Karpus,Kehuan Luo,Borko Jovanovic,Ann Traynor,Karyn Karlin,Dusan Stefoski,William H. Burns
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia
Clinical Trials & Observations
Hagop Kantarjian,Varsha Gandhi,Jorge Cortes,Srdan Verstovsek,Min Du,Guillermo Garcia-Manero,Francis Giles,Stefan Faderl,Susan O'Brien,Sima Jeha,Jan Davis,Zeev Shaked,Adam Craig,Michael Keating,William Plunkett,Emil J Freireich
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance
Clinical Trials & Observations
Christian M. Zwaan,Soheil Meshinchi,Jerald P. Radich,Anjo J. P. Veerman,Dieuwke R. Huismans,Leonhard Munske,Martina Podleschny,Karel Hählen,Rob Pieters,Martin Zimmermann,Dirk Reinhardt,Jochen Harbott,Ursula Creutzig,Gertjan J. L. Kaspers,Frank Griesinger
GENE THERAPY
Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy
Dirk Grimm,Shangzhen Zhou,Hiroyuki Nakai,Clare E. Thomas,Theresa A. Storm,Sally Fuess,Takashi Matsushita,James Allen,Richard Surosky,Michael Lochrie,Leonard Meuse,Alan McClelland,Peter Colosi,Mark A. Kay
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand
P. Toby H. Coates,Simon M. Barratt-Boyes,Linyou Zhang,Vera S. Donnenberg,Peta J. O'Connell,Alison J. Logar,F. Jason Duncan,Michael Murphey-Corb,Albert D. Donnenberg,Adrian E. Morelli,Charles R. Maliszewski,Angus W. Thomson
A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- γc-/- double-mutant mice
Rozemarijn S. van Rijn,Elles R. Simonetti,Anton Hagenbeek,Marieke C. H. Hogenes,Roel A. de Weger,Marijke R. Canninga-van Dijk,Kees Weijer,Hergen Spits,Gert Storm,Louis van Bloois,Ger Rijkers,Anton C. M. Martens,Saskia B. Ebeling
NEOPLASIA
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
Clinical Trials & Observations
Rafael Fonseca,Carina S. Debes-Marun,Elisa B. Picken,Gordon W. Dewald,Sandra C. Bryant,Jerry M. Winkler,Emily Blood,Martin M. Oken,Rafael Santana-Dávila,Natalia González-Paz,Robert A. Kyle,Morie A. Gertz,Angela Dispenzieri,Martha Q. Lacy,Philip R. Greipp
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases
Clinical Trials & Observations
Randy D. Gascoyne,Laurence Lamant,Jose I. Martin-Subero,Valia S. Lestou,Nancy Lee Harris,Hans-Konrad Müller-Hermelink,John F. Seymour,Lynda J. Campbell,Douglas E. Horsman,Isabelle Auvigne,Estelle Espinos,Reiner Siebert,Georges Delsol
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
Laurence Catley,Ellen Weisberg,Yu-Tzu Tai,Peter Atadja,Stacy Remiszewski,Teru Hideshima,Nicholas Mitsiades,Reshma Shringarpure,Richard LeBlanc,Dharminder Chauhan,Nikhil C. Munshi,Robert Schlossman,Paul Richardson,James Griffin,Kenneth C. Anderson
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
Brief Report
Pascale De Paepe,Mathijs Baens,Han van Krieken,Bruno Verhasselt,Michel Stul,Annet Simons,Bruce Poppe,Geneviève Laureys,Paul Brons,Peter Vandenberghe,Frank Speleman,Marleen Praet,Chris De Wolf-Peeters,Peter Marynen,Iwona Wlodarska
PHAGOCYTES
RED CELLS
TRANSPLANTATION
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials
Clinical Trials & Observations
Sergio Giralt,William Bensinger,Mark Goodman,Donald Podoloff,Janet Eary,Richard Wendt,Raymond Alexanian,Donna Weber,David Maloney,Leona Holmberg,Joseph Rajandran,Hazel Breitz,Richard Ghalie,Richard Champlin
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals